查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1465989

自訂抗體市場：按類型、按服務、按來源、按研究領域、按最終用戶、按應用 - 2024-2030 年全球預測

Custom Antibody Market by Type, Service, Source, Research Area, End Users, Application - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年自訂抗體市場規模為7.5586億美元，預計2024年將達到8.7188億美元，2030年將達到21.499億美元，複合年成長率為16.10%。

自訂抗體是專門設計和製造的蛋白質，用於特異性結合單一目標分子（稱為抗原）。這些抗體經過客製化，可識別目標分子上的獨特位點並以高特異性結合，使其成為研究、診斷和治療應用中的寶貴工具。抗體的自訂化生產使研究人員能夠為新的或研究較少的標靶創建特異性試劑，或創建具有商業上無法獲得的所需特性的抗體。由於慢性病和感染疾病在世界各地的流行，需要開發新的診斷和治療抗體。生物製藥公司和學術機構擴大投資於研發，支持自訂抗體的普及。然而，抗體生產需要複雜的步驟且成本高昂，而且抗體療法的嚴格監管要求減緩了市場進入並增加了開發成本。此外，產生具有高特異性和親和性的抗體仍然具有挑戰性，影響了自訂抗體應用的有效性。然而，主要企業正在探索人工智慧/機器學習演算法和機器人技術的整合，以簡化抗體發現和設計的過程。此外，更有效的融合瘤技術和重組抗體生產的開發，以及靶向藥物傳輸系統和診斷成像的擴大應用，也可能有助於產業成長。

主要市場統計
基準年[2023] 75586萬美元
預測年份 [2024] 87188萬美元
預測年份 [2030] 21.499 億美元
複合年成長率（%） 16.10%

對單株抗體應對嚴重的新需求

單株抗體是由單一 B 細胞克隆產生的相同抗體。這些抗體對單一抗原決定位具有高度特異性，使其可用於研究、診斷和治療，特別是在癌症、自體免疫疾病和感染疾病的治療中。多株抗體因其針對單一抗原的特異性和一致性而被選擇，這使得它們成為靶向特定分子途徑很重要的治療的理想選擇。多株抗體源自於不同的免疫細胞，可辨識抗原上的多個抗原決定位。這使其用途極為廣泛，並廣泛應用於研究應用，特別是用於檢測和精製各種蛋白質。它因其識別多個表位並提高診斷測定靈敏度的能力而受到青睞，使其在研究環境中的蛋白質檢測和分析中特別有用。重組抗體是利用重組 DNA 技術在體外生產的。此類別包括單域抗體和片段抗體。其高度可自訂的性質使其適用於從研究到治療用途的廣泛應用。它被選用於需要高特異性和重現性且無批次間差異的應用，如多株抗體，並且適用於治療藥物和體外診斷。

最終用戶製藥和生物技術公司增加對藥物開發和診斷的投資

學術和研究機構正在大力投資基礎和應用研究計劃，這些項目需要自訂抗體來獲得對生物過程和疾病機制的新見解。高度特異性和可自訂的選項優選用於各種研究環境，包括蛋白質體學和基因組學研究。由於預算限制，這些研究機構重視提供技術支援和有競爭力的價格的提供者。委外研發機構(CRO) 充當製藥公司和研究活動之間的聯絡人，代表其客戶進行廣泛的臨床試驗和研究計劃。 CRO 對自訂抗體的需求是高再現性、大批量訂單以及滿足計劃時間表和監管標準的時間效率。 CRO 尤其喜歡能夠提供廣泛文件和驗證服務的供應商。醫院和診所主要使用自訂抗體用於診斷目的和個人化醫療。該領域需要高度準確且經過臨床檢驗的抗體，可用於診斷和患者監測。能夠在臨床試驗階段和監管核准過程中提供強力支持的供應商受到高度重視。製藥和生物技術公司的自訂抗體需求佔大部分，主要是在藥物發現和藥物開發過程中。這些公司正在優先考慮可以作為生物標記整合到高通量篩檢、治療應用和臨床試驗中的抗體。這些公司正在尋找能夠大規模提供一致品質的產品、擁有完整的文件並符合監管標準的供應商。

區域洞察

以美國和加拿大為中心的美洲地區以其強大的研究環境而聞名，對自訂抗體的需求做出了巨大貢獻。該地區強大的生物技術和製藥行業正在推動這一需求，學術和商業研究機構都在尋求用於治療和診斷用途的高品質、特異性抗體。美國最近的專利顯示了對新型癌症生物標記和神經退化性疾病的關注，突顯了抗體開發領域的持續創新。歐盟（EU）國家擁有先進的醫療保健系統和對生物技術研究強力的監管支持，創造了有利於研究和開發的環境。歐盟對治療和診斷分子有嚴格的規定，為自訂抗體的開發提供了標準化和安全的框架。歐盟最近的投資重點是透過創新的抗體解決方案對抗感染疾病和解決自體免疫疾病等慢性病。亞太地區在市場格局中佔據著舉足輕重的地位，政府資助了多項旨在改善衛生基礎設施並增加邊緣人群獲得診斷和治療的機會的舉措。中國專注於生物技術創新以及政府對基因組學和蛋白​​質組學研究的投資，創造了高度專業化抗體的需求。日本成熟的製藥業優先考慮精準醫療，而印度蓬勃發展的生物技術產業，加上具有成本效益的製造能力，對自訂抗體的成長至關重要。

FPNV定位矩陣

FPNV定位矩陣對於評估自訂抗體市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對自訂抗體市場中供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.自訂抗體市場的市場規模和預測是多少？

2.自訂抗體市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些？

3.自訂抗體市場的技術趨勢和法規結構是什麼？

4.自訂抗體市場主要廠商的市場佔有率為何？

5. 進入自訂抗體市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球慢性感染疾病病率增加
      • 擴展自訂抗體在研究、診斷和治療領域的應用
      • 更多採用抗體工程和個人化治療的先進技術
    • 抑制因素
      • 開發自訂抗體需要大量時間和精力。
    • 機會
      • 政府和私營部門對生命科學和臨床研究進行策略性投資
      • 抗體療法的增加和藥物管道的擴展
    • 任務
      • 替代抗體的存在
  • 市場區隔分析
    • 類型：對單株抗體解決嚴重的新興需求
    • 最終用戶：製藥和生技公司增加對藥物開發和診斷的投資
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章自訂抗體市場：依類型

  • 單株抗體
  • 多株抗體
  • 重組抗體

第7章自訂抗體市場：依服務分類

  • 抗體開發
  • 抗體片段化和標記
  • 抗體生產和精製

第 8 章自訂抗體市場：依來源分類

  • 老鼠
  • 兔子

第 9 章自訂抗體市場研究（按領域）

  • 心血管疾病
  • 免疫學
  • 感染疾病
  • 神經生物學
  • 腫瘤學
  • 幹細胞

第 10 章自訂抗體市場：依最終用戶分類

  • 學術研究所
  • 合約調查機構
  • 醫院/診所
  • 製藥和生物技術公司

第11章自訂抗體市場：依應用分類

  • 調查
  • 治療藥物

第12章美洲客自訂抗體市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第13章亞太地區自訂抗體市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第14章 歐洲、中東、非洲自訂抗體市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 丹納赫將以 57 億美元收購抗體供應商 Abcam
    • 默克斥資 108 億美元收購單株抗體
    • Celltrion 和 Genuve 合作開發新的治療抗體
  • 戰略分析和建議

第16章競爭組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-46132FF79A8E

[188 Pages Report] The Custom Antibody Market size was estimated at USD 755.86 million in 2023 and expected to reach USD 871.88 million in 2024, at a CAGR 16.10% to reach USD 2,149.90 million by 2030.

Custom antibodies are specialized proteins designed and produced to bind specifically to a single target molecule, known as an antigen. These antibodies are tailor-made to recognize and bind with high specificity to unique sites on target molecules, making them valuable tools in research, diagnostic, and therapeutic applications. The custom production of antibodies allows researchers to generate specific reagents for novel or less-studied targets or to create antibodies with desired properties that are not available off the shelf. The high prevalence and incidences of chronic and infectious diseases worldwide necessitate the development of novel diagnostic and therapeutic antibodies. Heightened investment in research and development by biopharmaceutical companies and academic institutions boosts the proliferation of custom antibodies. However, the intricate processes involved in custom antibody production can be cost-intensive, and stringent regulatory requirements for antibody therapeutics can delay market entry and increase development costs. Moreover, generating antibodies with high specificity and affinity remains challenging, impacting the effectiveness of custom antibody applications. However, key players are exploring the integration of AI/ML algorithms and robotics technologies to ease the process of antibody discovery and design. Furthermore, the development of more efficient hybridoma technology and recombinant antibody production and expanding applications in targeted drug delivery systems and diagnostic imaging could also benefit the growth of the industry.

KEY MARKET STATISTICS
Base Year [2023] USD 755.86 million
Estimated Year [2024] USD 871.88 million
Forecast Year [2030] USD 2,149.90 million
CAGR (%) 16.10%

Type: Emerging need for monoclonal antibodies to tackle severe disease states

Monoclonal antibodies are identical antibodies produced by a single B-cell clone. These antibodies are highly specific to a single epitope, making them valuable in research, diagnostic, and therapeutic contexts, particularly for the treatment of cancers, autoimmune diseases, and infectious diseases. They are chosen for their specificity and consistency in targeting a single antigen and are ideal in therapeutic contexts where targeting a specific molecular pathway is crucial. Polyclonal antibodies are derived from different immune cells and recognize multiple epitopes on an antigen. This makes them extremely versatile and widely used in research applications, particularly for detecting and purifying a wide variety of proteins. They are preferred for their ability to recognize multiple epitopes, enhancing sensitivity in diagnostic assays, and are particularly valuable in research settings for protein detection and analysis. Recombinant antibodies are engineered in vitro using recombinant DNA technology. This category includes single-domain antibodies and fragment antibodies. Their highly customizable nature makes them suitable for a broad range of applications, from research to therapeutic use. They are selected for applications requiring high specificity and reproducibility without the batch-to-batch variation seen in polyclonal antibodies and are suited for therapeutics and in vitro diagnostics.

End Users: Expanding investments by the pharmaceutical & biotechnology companies in drug development and diagnostics

Academic and research institutes significantly invest in basic and applied research projects that require custom antibodies to uncover novel insights into biological processes and disease mechanisms. Their preference leans towards highly specific, customizable options that can be used in various research settings, including proteomics and genomics studies. These entities value providers that offer technical support and competitive pricing due to budget constraints. Contract research organizations (CROs) serve as a bridge between pharmaceutical companies and research activities, conducting a wide array of clinical trials and research projects on behalf of their clients. Their need for custom antibodies revolves around high reproducibility, bulk orders, and time efficiency to meet project timelines and regulatory standards. Notably, CROs prefer vendors that can provide extensive documentation and validation services. Hospitals and clinics primarily utilize custom antibodies for diagnostic purposes and in personalized medicine applications. The demand within this sector is for highly accurate, clinically validated antibodies that can be used in diagnostics and patient monitoring. Suppliers that can offer robust support in clinical trial phases and regulatory approval processes are highly valued. Pharmaceutical and biotechnology companies represent a significant portion of the need for custom antibodies, mainly for drug discovery and development processes. These companies prioritize antibodies that can be integrated into high-throughput screenings, therapeutic applications, and as biomarkers in clinical trials. They seek vendors that are capable of providing large-scale, consistent quality products with thorough documentation and compliance with regulatory standards.

Regional Insights

The Americas, particularly the U.S. and Canada, are known for their robust research environments, contributing significantly to the demand for custom antibodies. The region's strong biotechnology and pharmaceutical sectors drive this need, with both academic and commercial labs seeking high-quality, specific antibodies for therapeutic and diagnostic applications. Recent patents in the U.S. indicate a focus on novel cancer biomarkers and neurodegenerative diseases, highlighting the ongoing innovation in antibody development. European Union (EU) countries boast advanced healthcare systems and strong regulatory support for biotechnology research, fostering a conducive environment for custom antibody development. The presence of stringent regulations for therapeutics and diagnostics molecules in the EU provides a standardized and secure framework for the progression of custom antibodies. Recent EU investments focus on combating infectious diseases and addressing chronic conditions, such as autoimmune disorders, through innovative antibody solutions. The APAC region has emerged as a pivotal landscape in the custom antibody market, supported by several government-funded initiatives to advance the healthcare infrastructure and provide marginalized communities access to diagnostics and therapeutic capabilities. China's focus on biotechnology innovation and government investments in genomics and proteomics research is creating a need for highly specialized antibodies. Japan's well-established pharmaceutical industry prioritizes precision medicine, and India's burgeoning biotechnology sector, coupled with its cost-effective manufacturing capabilities, has proved crucial for the growth of custom antibodies.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Custom Antibody Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Custom Antibody Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Custom Antibody Market, highlighting leading vendors and their innovative profiles. These include Abbiotec, Inc., Abcam PLC, ABclonal, Inc., Abgenex Pvt. Ltd., Abnova Corporation, Acrobiosystems Inc., Agilent Technologies, Inc., Alta Bioscience Limited, Bio Basic Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioChain Incorporated, Bioklone Biotech Private Limited, BioLegend, Inc. by PerkinElmer, Inc., Biosynth Ltd., Boster Biological Technology, BTL Biotechno Labs Private Limited, Capralogics, Inc., Cell Signaling Technology, Inc., CiteAb Limited, Creative Biolabs, Creative Diagnostics, CSBio (Shanghai) Ltd., Cusabio Technology LLC, Davids Biotechnologie GmbH, Elabscience, evitria AG by Atlas Antibiodies, GenScript Biotech Corporation, Imgenex India Pvt. Ltd., Innovagen AB, Inotiv, Inc., Kaneka Eurogentec S.A., Laboratory Corporation of America Holdings, Merck KGaA, Metabion International AG, MyBiosource, Inc., OriGene Technologies, Inc., Oy Medix Biochemica AB, Pacific Immunology, PhosphoSolutions, ProMab Biotechnologies, Inc., ProSci Incorporated, ProteoGenix SA, RayBiotech Life, Inc., Rockland Immunochemicals, Inc., Sino Biological, Inc., The Antibody Company, Thermo Fisher Scientific, Inc., and YenZym Antibodies, LLC.

Market Segmentation & Coverage

This research report categorizes the Custom Antibody Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Monoclonal Antibodies
    • Polyclonal Antibodies
    • Recombinant Antibodies
  • Service
    • Antibody Development
    • Antibody Fragmentation & Labeling
    • Antibody Production & Purification
  • Source
    • Mice
    • Rabbit
  • Research Area
    • Cardiovascular Diseases
    • Immunology
    • Infectious Diseases
    • Neurobiology
    • Oncology
    • Stem cells
  • End Users
    • Academic & Research Institutes
    • Contract Research Organizations
    • Hospitals & Clinics
    • Pharmaceutical & Biotechnology Companies
  • Application
    • Research
    • Therapeutics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Custom Antibody Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Custom Antibody Market?

3. What are the technology trends and regulatory frameworks in the Custom Antibody Market?

4. What is the market share of the leading vendors in the Custom Antibody Market?

5. Which modes and strategic moves are suitable for entering the Custom Antibody Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic infectious disease worldwide
      • 5.1.1.2. Expanding applications of custom antibody across research, diagnostics, and therapeutics
      • 5.1.1.3. Rising adoption of advanced technologies in antibody engineering and personalized therapeutics
    • 5.1.2. Restraints
      • 5.1.2.1. Extensive and time consuming to develop custom antibodies
    • 5.1.3. Opportunities
      • 5.1.3.1. Governments and private sector strategically investments in life science and clinical research
      • 5.1.3.2. Increase in therapeutics of antibodies and expansion of drug pipeline
    • 5.1.4. Challenges
      • 5.1.4.1. Presence of alternative antibodies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Emerging need for monoclonal antibodies to tackle severe disease states
    • 5.2.2. End Users: Expanding investments by the pharmaceutical & biotechnology companies in drug development and diagnostics
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Custom Antibody Market, by Type

  • 6.1. Introduction
  • 6.2. Monoclonal Antibodies
  • 6.3. Polyclonal Antibodies
  • 6.4. Recombinant Antibodies

7. Custom Antibody Market, by Service

  • 7.1. Introduction
  • 7.2. Antibody Development
  • 7.3. Antibody Fragmentation & Labeling
  • 7.4. Antibody Production & Purification

8. Custom Antibody Market, by Source

  • 8.1. Introduction
  • 8.2. Mice
  • 8.3. Rabbit

9. Custom Antibody Market, by Research Area

  • 9.1. Introduction
  • 9.2. Cardiovascular Diseases
  • 9.3. Immunology
  • 9.4. Infectious Diseases
  • 9.5. Neurobiology
  • 9.6. Oncology
  • 9.7. Stem cells

10. Custom Antibody Market, by End Users

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Contract Research Organizations
  • 10.4. Hospitals & Clinics
  • 10.5. Pharmaceutical & Biotechnology Companies

11. Custom Antibody Market, by Application

  • 11.1. Introduction
  • 11.2. Research
  • 11.3. Therapeutics

12. Americas Custom Antibody Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Custom Antibody Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Custom Antibody Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Danaher to Buy Antibody Supplier Abcam for USD 5.7 Billion
    • 15.3.2. Merck to Develop mAb Through USD 10.8 Billion Acquisition
    • 15.3.3. Celltrion and Genuv Partner to Develop Novel Therapeutic Antibodies
  • 15.4. Strategy Analysis & Recommendation

16. Competitive Portfolio

  • 16.1. Key Company Profiles
  • 16.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CUSTOM ANTIBODY MARKET RESEARCH PROCESS
  • FIGURE 2. CUSTOM ANTIBODY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CUSTOM ANTIBODY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CUSTOM ANTIBODY MARKET DYNAMICS
  • FIGURE 7. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 18. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 22. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 27. CUSTOM ANTIBODY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 28. CUSTOM ANTIBODY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CUSTOM ANTIBODY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CUSTOM ANTIBODY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CUSTOM ANTIBODY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RECOMBINANT ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RECOMBINANT ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY FRAGMENTATION & LABELING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY FRAGMENTATION & LABELING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY PRODUCTION & PURIFICATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY PRODUCTION & PURIFICATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY MICE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY MICE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RABBIT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RABBIT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY NEUROBIOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY NEUROBIOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY STEM CELLS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 119. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 134. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 154. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 156. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 158. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 160. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 161. CHINA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. CHINA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 165. CHINA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 166. CHINA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 167. CHINA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 168. CHINA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 169. CHINA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 170. CHINA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 171. CHINA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 172. CHINA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 173. INDIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 174. INDIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 177. INDIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 178. INDIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 179. INDIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 180. INDIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 181. INDIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 182. INDIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 183. INDIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. INDIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 188. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 189. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 190. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 191. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 192. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 193. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 194. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 195. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 198. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 199. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 200. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 201. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 202. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 203. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 204. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 205. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 206. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 207. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 208. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 209. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 210. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 211. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 212. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 213. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 214. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 215. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 216. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 217. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 218. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 219. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 220. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 224. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 226. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 228. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 230. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 232. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 233. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 234. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 235. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 236. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 237. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 238. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 239. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 240. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 241. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 242. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 243. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 257. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 258. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 259. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 260. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 261. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 262. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 263. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 264. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 265. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 266. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 267. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 272. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 273. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 274. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 275. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 276. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 277. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 278. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 279. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 280. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 281. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 282. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 283. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 284. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 285. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 286. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 287. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 288. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 289. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 290. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 291. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 292. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 307. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 308. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 309. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 310. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 311. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 312. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 313. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 314. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 315. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 316. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 317. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 318. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 319. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 320. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 321. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 322. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 323. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 324. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 325. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 326. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 327. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 328. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 329. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 330. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 331. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 332. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 333. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 334. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 335. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 336. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 337. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 338. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 339. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 340. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 341. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 342. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 343. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 344. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 345. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 346. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 347. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 348. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 349. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 350. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 351. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 352. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 353. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 354. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 355. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 356. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 357. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 358. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 359. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 360. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 361. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2023 (USD MILLION)
  • TABLE 362. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2024-2030 (USD MILLION)
  • TABLE 363. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 364. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 365. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 366. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 367. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 368. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 369. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2023 (USD MILLION)
  • TABLE 370. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2024-2030 (USD MILLION)
  • TABLE 371. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLI